Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
Clinical trial NCT02590263 · COMPLETED
Trial details
- NCT number
- NCT02590263
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-24
- Primary completion
- 2020-08-27
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.